A salmon-and-mushroom sushi roll proved deadly for two restaurant patrons in Montana last year, and experts are sounding the alarm on the dangers of undercooked morel mushrooms. A total of 51 patrons at an unnamed restaurant in Bozeman got very ill last April, including the two fatalities, and researchers soon traced the illnesses to undercooked… read on > read on >
The blockbuster weight-loss medication Zepbound (tirzepatide) appears to help folks quickly shed pounds regardless of how overweight they are, or how long they’ve lived being overweight or obese. Those are the findings of two separate analyses of a major trial of the injected drug that was funded by maker Eli Lilly. “Regardless of baseline BMI,… read on > read on >
Nurses who specialize in anesthesia have issued new guidelines to reduce the risk that patients taking weight-loss drugs like Ozempic or Wegovy throw up during surgery. “These medications have exploded in popularity,” said Micah Walden, of the American Association of Nurse Anesthesiology (AANA) Practice Committee. “This means additional preparation for patients, anesthesia providers and the surgical… read on > read on >
Be sure to check your fridge for any Johnsonville turkey kielbasa sausage — over 35,000 pounds of the product is under recall due to some customers finding “pieces of rubber” in the packaged meat. Denmark, Wisc.-based Salm Partners, which makes the sausage, said the products under recall were made Oct 30 and 31 and shipped… read on > read on >
Women who’ve gone through menopause and hope that supplemental vitamin D plus calcium might shield them from disease may be disappointed by new data. A follow-up analysis of data from the landmark Women’s Health Initiative trial found the supplement combo lowered a woman’s long-term odds of dying from cancer by 7%. However, it also raised… read on > read on >
Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, but the company stopped just short of saying it will definitely pull the drug from the market. The… read on > read on >
Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart attack, stroke and heart death. “Wegovy is now the first weight-loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity… read on > read on >
Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the drug’s maker said Friday. “The FDA has informed Lilly it wants to further understand topics related to evaluating the safety and… read on > read on >
Folks worried about becoming flabby in middle age should check out what their parents looked like when they were that age, a new study says. People are six times more likely to become obese in middle age if both their parents were chubby during that time of their lives, according to research to be presented… read on > read on >
Children with “lazy eye” are more likely to become adults facing an array of serious health problems, a new study warns. Kids diagnosed with amblyopia are more likely to develop high blood pressure, obesity and diabetes as adults, researchers found. They also face an increased risk of heart attack, according to findings published March 7… read on > read on >
